BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38523374)

  • 1. Management of pediatric hemolytic uremic syndrome.
    Gülhan B; Özaltın F; Fidan K; Özçakar ZB; Söylemezoğlu O
    Turk J Pediatr; 2024; 66(1):1-16. PubMed ID: 38523374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
    J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atypical HUS caused by complement-related abnormalities].
    Yoshida Y; Matsumoto M
    Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where are we with haemolytic uremic syndrome?
    Cavero T; Alonso M
    Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Hemolytic Uremic Syndrome in a Pregnant Patient with a Thrombomodulin Gene Variant Treated with Plasma Exchange and Eculizumab.
    Kannan L
    Am J Case Rep; 2023 Apr; 24():e938896. PubMed ID: 37120715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombotic microangiopathies in surgical intensive care medicine with special consideration of atypical hemolytic uremic syndrome].
    Albrecht S; Kamla CE; Schönermarck U; Wassilowsky D
    Anaesthesiologie; 2023 Jan; 72(1):3-12. PubMed ID: 36454255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
    Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.
    Avdonin PP; Blinova MS; Generalova GA; Emirova KM; Avdonin PV
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical guides for atypical hemolytic uremic syndrome in Japan.
    Kato H; Nangaku M; Hataya H; Sawai T; Ashida A; Fujimaru R; Hidaka Y; Kaname S; Maruyama S; Yasuda T; Yoshida Y; Ito S; Hattori M; Miyakawa Y; Fujimura Y; Okada H; Kagami S;
    Clin Exp Nephrol; 2016 Aug; 20(4):536-543. PubMed ID: 27422619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.
    Cheong HI; Jo SK; Yoon SS; Cho H; Kim JS; Kim YO; Koo JR; Park Y; Park YS; Shin JI; Yoo KH; Oh D
    J Korean Med Sci; 2016 Oct; 31(10):1516-28. PubMed ID: 27550478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
    Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
    Raina R; Krishnappa V; Blaha T; Kann T; Hein W; Burke L; Bagga A
    Ther Apher Dial; 2019 Feb; 23(1):4-21. PubMed ID: 30294946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome.
    Tsai HM
    Transfus Med Rev; 2014 Oct; 28(4):187-97. PubMed ID: 25280590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report.
    Wei X; Li J; Zhan X; Tu L; Huang H; Wang Y
    J Med Case Rep; 2022 Mar; 16(1):101. PubMed ID: 35241161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical hemolytic uremic syndrome: Consensus of diagnosis and treatment in Taiwan.
    Tseng MH; Lin SH; Tsai JD; Wu MS; Tsai IJ; Chen YC; Chang MC; Chou WC; Chiou YH; Huang CC
    J Formos Med Assoc; 2023 May; 122(5):366-375. PubMed ID: 36323601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy.
    Korzycka J; Pawłowicz-Szlarska E; Masajtis-Zagajewska A; Nowicki M
    Am J Case Rep; 2022 Oct; 23():e936565. PubMed ID: 36306276
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.